Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

Documenti analoghi

• Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer
  di: Chiarion-Sileni, V, et al.
  Pubblicazione: (2007)
• Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
  di: Zhang, Peng, et al.
  Pubblicazione: (2016)
• Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancer
  di: Zhang, T.W., et al.
  Pubblicazione: (2018)
• Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
  di: Michel, P, et al.
  Pubblicazione: (2006)
• A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC
  di: Michael, M, et al.
  Pubblicazione: (2005)